Video & Multimedia
Related: About this forumViable Coronavirus Test Kits Awaiting FDA Approval MSNBC
&feature=push-fr&attr_tag=6d9nJUHqM9vGCNFk%3A6rurallib
(62,406 posts)want to look bad when the real numbers come in. I would make him look like a liar and out of touch and trying to cover up the real crisis.
PaulRevere08
(449 posts)Last edited Thu Mar 12, 2020, 06:29 PM - Edit history (1)
gratification. Lie and bully to get his way. He got away with it because people usually wanted something from him as well and it was the price they had to pay. Even if it went bad it was only $$$$. But now, lives, many lives are at stake and he just can't brush it off. He has never experienced this and he has no skill or inner-strength to deal with it.
Not that the weasel Pence will have the guts or moral fiber to push past tRump and do what is needed.
SergeStorms
(19,193 posts)another government agency Trump has gutted and "privatized".
http://www.sciencemag.org/news/2019/07/exclusive-fda-enforcement-actions-plummet-under-Trump
From monitoring clinical trials and approving medicines and vaccines, to ensuring the safety of blood transfusions, medical devices, groceries, and more, the U.S. Food and Drug Administration (FDA) is one of the nations most vital watchdogs. By several measures, however, FDAs compliance and enforcement actions have plummeted since President Donald Trump took office, Science has found.
The agencys warning lettersa key tool for keeping dangerous or ineffective drugs and devices and tainted foods off the markethave fallen by one-third, for example. Such letters typically demand swift corrections to protect public health and safety. FDA records from Trumps inauguration through 22 May show the agency issued 1033 warning letters, compared with 1532 for the most recent equivalent period under former President Barack Obama. Compared with the start of the Obama presidency, Trump-era letters dropped by nearly half.
Warnings from the FDA Center for Devices and Radiological Health, which helps ensure the safety and quality of medical devices, and from some of the agencys district officesincluding Philadelphia, Florida, and New Yorkhave dropped even more steeply, by more than two-thirds. Two district offices have not issued a warning in more than 2 years. The numbers dont just reflect a new administrations slow start. FDA sent significantly fewer warning letters in the second year of Trumps presidency than in his first.